FIELD: medicine. SUBSTANCE: preparation has gamma-globulin (0.6 mg), histamine (0.0002 mg) and serotonin (0.002 mg) per 1 ml saline solution. EFFECT: increased therapeutic effect, prolonged remission, broadened sphere of usage. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ALLERGIC DISEASES TREATMENT | 0 |
|
SU1792329A3 |
METHOD OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2340348C1 |
METHOD FOR ALLERGIC DISEASE TREATMENT | 0 |
|
SU1793923A3 |
METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
METHOD OF TREATING ALLERGIC DISEASES BY AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2395305C1 |
METHOD FOR PREVENTING AUTOIMMUNE THYROIDITIS IN THE COURSE OF ALLERGEN-SPECIFIC THERAPY | 2021 |
|
RU2775129C1 |
METHOD OF TREATING ALLERGIC DISEASES | 2020 |
|
RU2742976C1 |
METHOD FOR TREATING THE CASES OF ALLERGIC DISEASES | 2004 |
|
RU2250773C1 |
METHOD FOR TREATMENT OF PATIENTS WITH ALLERGIC DISEASES BY AUTOLOGICAL LYMPHOCYTES | 2015 |
|
RU2633343C2 |
METHOD FOR TREATING INFECTIOUS ALLERGIC RHINOSINUSOPATHY | 1996 |
|
RU2121359C1 |
Authors
Dates
1996-02-27—Published
1992-09-15—Filed